Delivery Order SPE2DR25D1202-SPE2DR26F71YX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,446.90 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,360.45 for Mounjaro 15 mg/0.5 ml pen injectors on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $58,321.91 under firm fixed pricing. This is a non-set-aside competitively awarded delivery order with an ultimate completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $11,349.70 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors with a ceiling value of $5,856.76. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 30, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a ceiling value of $4,871.43. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,203.41 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on May 21, 2025, with an ultimate completion date of May 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $10,536.80 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The contract involves no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $9,191.62 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, which is expected to be completed by November 7, 2025, was awarded competitively with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,766.11 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on September 11, 2025, with completion scheduled for September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71YXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,720.17 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This competitive award, with no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of November 6, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for supplying pharmaceuticals and medical supplies to military healthcare systems globally. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare programs. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical requirements, ranging from specialty medications to vaccines and medical devices across multiple therapeutic domains. This delivery order for Mounjaro, a diabetes medication, exemplifies the company's role in supporting military personnel and veteran healthcare needs through the DLA's comprehensive medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/5/25 |